Axalbion Therapeutics Limited

Manufacture of basic pharmaceutical products · Altrincham

ActiveUnited KingdomIncorporated 2021Private Limited Company

Financial position

Accounts to 2025-12-31 · GBP · company scope

Net assets

£4,910,631

Cash

£2,499,914

Turnover

—

Profit / loss

−£3,724,142

Current assets

£2,753,089

Creditors < 1 year

£470,120

Equity

£4,910,631

Average employees

GBP · company

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods

Reported figures	2025-12-31GBP · company	2024-12-31GBP · company	2023-12-31Unknown currency · company	2022-12-31GBP · unknown	2021-12-31GBP · unknown
Balance sheet
Net assets	£4,910,631	£8,305,097	—	£4,624,798	£733,782
Equity	£4,910,631	£8,305,097	—	£4,624,798	£733,782
Assets
Fixed assets	£4,252,430	£4,536,427	—	—	—
Intangible assets	£1,477,216	£1,761,213	—	—	—
Current assets	£2,753,089	£6,214,006	—	£1,035,872	£1,092,199
Cash at bank	£2,499,914	£5,031,187	—	£46,883	£433,454
Debtors	£253,175	£1,182,819	—	£988,989	£658,745
Liabilities
Creditors within one year	£470,120	£607,269	—	£353,882	£358,417
Creditors after one year	£1,624,768	£1,838,067	—	£521,591	—
Net current assets	£2,282,969	£5,606,737	—	£681,990	£733,782
Assets less current liabilities	£6,535,399	£10,143,164	—	£5,146,389	£733,782
Profit & loss
Profit / loss	−£3,724,142	−£5,435,053	—	—	—
People
Average employees	7	7	—	7	7
Source evidence	View filing	View filing	View filing	View filing	View filing